Exabis Library
Welcome to the e-CCO Library!
P348: Top down versus step-up strategies to prevent postoperative recurrence in Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P349 Infliximab in inflammatory bowel disease: Is premedication necessary?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P349: Cyclosporine has no clinically meaningful effect on pharmacokinetics (PK) of BMS-986165, an oral selective tyrosine kinase 2 (TYK2) inhibitor, in healthy subjects
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P349: Deep enteroscopy with a through-the-scope ballon catheter system in paediatric patients with IBD
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P349: Faecal Calprotectin in Ulcerative Colitis - Associations with Mucosal Inflammatory Activity and Disease Extent
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P349: Safety of Inflammatory Bowel Disease treatments in patients with Solid Organ Transplantation (EITOS study of GETECCU).
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P349: The effects of smoking on thiopurine metabolism
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P349: The therapies influencing postoperative surgical recurrence in Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P350 Perceptions of faecal microbiota transplantation in patients with ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P350: Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P350: Conventional biomarkers in newly diagnosed Crohn’s disease patients may predict early disease progression
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P350: Endoscopic sedation in IBD patients: a propensity score-matched retrospective study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P350: Induction of antiphospholipid antibodies in patients with inflammatory bowel disease treated with anti-TNFα agents
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P350: Real-world data regarding treatment of ulcerative colitis patients with golimumab in Switzerland
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P350: SAFIIR: Study of Anemia Following Intravenous Iron Repletion
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P350: The use of concomitant immunomodulators with adalimumab therapy in paediatric Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P351 Spontaneous intra-abdominal abscesses in Crohn’s disease: The experience of a tertiary centre
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P351: Allogenic adipose-derived mesenchymal stem cells (darvadstrocel) in Japanese patients with complex perianal fistulas in Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P351: Bowel ultrasound is accurate in assessing disease activity in ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM